EPCAM and neoplasm: To test whether the higher resistance of EPCAM− tumour cells to chemotherapy is related to the higher ability to cope with replicative stress, we evaluated the sensitivity of EPCAM+, EPCAM− and Rhoj-KO tumour cells to the replicative-stress-inducing drug aphidicolin.